FDA 510(k)

Multi-Lancet Device 2, ReliOn Premier Lancing Device

Número K: K221175 · 2022-10-17

Data da decisão2022-10-17

Código do produtoQRL

Comité consultivoSU

DecisãoSubstantially Equivalent

Resumo do dispositivo

Multi-Lancet Device 2, ReliOn Premier Lancing Device is the device name listed in this FDA 510(k) record. The listed applicant is Arkray, Inc.. It received FDA 510(k) clearance on 2022-10-17 under 510(k) number K221175. The device is classified under product code QRL. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the Multi-Lancet Device 2, ReliOn Premier Lancing Device?

Multi-Lancet Device 2, ReliOn Premier Lancing Device is a medical device that received FDA 510(k) clearance on 2022-10-17. The listed applicant is Arkray, Inc.. The 510(k) number is K221175.

When did Multi-Lancet Device 2, ReliOn Premier Lancing Device receive FDA 510(k) clearance?

Multi-Lancet Device 2, ReliOn Premier Lancing Device received FDA 510(k) clearance on 2022-10-17, under 510(k) number K221175.

Who is the listed applicant for Multi-Lancet Device 2, ReliOn Premier Lancing Device?

The FDA 510(k) record lists Arkray, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Multi-Lancet Device 2, ReliOn Premier Lancing Device?

The FDA product code for Multi-Lancet Device 2, ReliOn Premier Lancing Device is QRL.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Outros registros que listam Arkray, Inc. como candidato(a)

K232416SISTEMA DE ANÁLISE DE PARTÍCULAS DE URINA AUTION EYE AI-4510 K193514SISTEMA DE ANÁLISE DE URINA AUTION MAX AX-4060 K200788Assure Titanium Blood Glucose Monitoring System K160062SISTEMA DE ANÁLISE DE URINA AUTION ELEVEN Semi-Automatizado

Dispositivos Relacionados (Código: QRL)

K262135Lancing deviceTianjin Huahong Technology Co., Ltd.K262211LancetTianjin Huahong Technology Co., Ltd.K260122Lancing Device (PressGo, LDE3, LDE3AST, LDE5, EasyStep)SteriLance Medical (Suzhou), Inc.K253706Lancing device (HH-XV-T)Tianjin Huahong Technology Co., Ltd.K250813MICROLET®NEXT 2 Lancing DeviceAscensia Diabetes Care U.S., Inc.K243306Lancet (IA, IB, IC, ID, IE, IK, IL, IM, IIA, IIB, III, V, VI, VII, VIII, IX); Lancing device (HH-X-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T, HH-XXV-T, HH-XXVI-T, HH-XXVIII-T, HH-XXIX-T, HH-XXX-T, HH-XIII-T, HH-XXVII-T)Tianjin Huahong Technology Co., Ltd.

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.